KYNB is expected to report earnings to fall 15.43% to -318 cents per share on August 10
Q2'26
Est.
$-3.18
Q1'26
Missed
by $3.55
Q4'25
Missed
by $3.37
The last earnings report on May 11 showed earnings per share of -375 cents, missing the estimate of -20 cents. With 16.36K shares outstanding, the current market capitalization sits at 30.79M.
A.I.dvisor indicates that over the last year, KYNB has been loosely correlated with ACXP. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if KYNB jumps, then ACXP could also see price increases.
KYNB saw its Stochastic Oscillator recovers from the overbought zone
The Stochastic Oscillator for KYNB moved out of overbought territory on July 07, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 57 similar instances where the indicator exited the overbought zone. In of the 57 cases the stock moved lower. This puts the odds of a downward move at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for KYNB moved out of overbought territory on July 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KYNB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
KYNB broke above its upper Bollinger Band on June 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for KYNB entered a downward trend on June 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on June 22, 2026. You may want to consider a long position or call options on KYNB as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for KYNB just turned positive on June 12, 2026. Looking at past instances where KYNB's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
KYNB moved above its 50-day moving average on June 26, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for KYNB crossed bullishly above the 50-day moving average on June 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KYNB advanced for three days, in of 271 cases, the price rose further within the following month. The odds of a continued upward trend are .
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (22.885). P/E Ratio (0.000) is within average values for comparable stocks, (37.796). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.508). KYNB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.038). P/S Ratio (4.136) is also within normal values, averaging (434.181).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KYNB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KYNB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Kyntra Bio (KYNB) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com
